Importer of Controlled Substances Application: ABBVIE LTD; Correction
The Drug Enforcement Administration (DEA) published a document in the Federal Register of December 1, 2017, concerning a notice of application that inadvertently misstated what the firm plans to do with imported tapentadol.
Schedules of Controlled Substances: Temporary Placement of Fentanyl-Related Substances in Schedule I
The Administrator of the Drug Enforcement Administration is publishing this notice of intent to issue an order temporarily scheduling fentanyl-related substances that are not currently listed in any schedule of the Controlled Substances Act (CSA). The temporary order will place these substances in schedule I. This action is based on a finding by the Administrator that the placement of these synthetic opioids in schedule I is necessary to avoid an imminent hazard to the public safety. When it is issued, the temporary scheduling order will impose regulatory requirements under the CSA on the manufacture, distribution, reverse distribution, possession, importation, exportation, research, and conduct of instructional activities, and chemical analysis of these synthetic opioids, as well as administrative, civil, and criminal remedies with respect to persons who fail to comply with such requirements or otherwise violate the CSA with respect to these substances.